Review Article | DOI: https://doi.org/BRCA-RW-26-40
Resveratrol and Trans-Resveratrol in Respiratory Diseases: Immunobiological Mechanisms and Public Health Implications
Abstract
Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), represent a significant global public health burden due to their high prevalence, morbidity, and socioeconomic impact. Persistent airway inflammation, oxidative stress, and immune dysregulation are central mechanisms underlying disease progression and exacerbations. Resveratrol and its biologically active isomer, trans-resveratrol, are naturally occurring polyphenols widely investigated for their antioxidant, anti-inflammatory, and immunomodulatory properties. This mini-review summarizes current evidence on the biological effects of resveratrol and trans-resveratrol in the respiratory system, focusing on their molecular targets, signaling pathways, and immunobiological actions relevant to asthma and COPD. Special emphasis is placed on their potential role as preventive and adjuvant strategies from a public health perspective. The available data support resveratrol as a context-dependent immunomodulator capable of attenuating chronic airway inflammation while preserving essential host defense mechanisms.
References
-
Global Initiative for Asthma. Global strategy for asthma management and prevention. 2024.
View at Publisher | View at Google Scholar -
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD. 2024.
View at Publisher | View at Google Scholar -
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16-27.
View at Publisher | View at Google Scholar -
Rabe KF, et al. Asthma. Nat Rev Dis Primers. 2018;4:18001.
View at Publisher | View at Google Scholar -
Berman AY, et al. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1:35.
View at Publisher | View at Google Scholar -
Fremont L. Biological effects of resveratrol. Life Sci. 2000;66:663-673.
View at Publisher | View at Google Scholar -
Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011;1215:9-15.
View at Publisher | View at Google Scholar -
Patel KR, et al. Clinical pharmacology of resveratrol. Ann N Y Acad Sci. 2011;1215:161-9.
View at Publisher | View at Google Scholar -
Csiszar A, et al. Resveratrol inhibits NF-κB activation. Am J Physiol Heart Circ Physiol. 2006;291:H1694-9.
View at Publisher | View at Google Scholar -
Donnelly LE, Barnes PJ. Expression and regulation of inducible nitric oxide synthase in human lung. Am J Respir Crit Care Med. 2002;165:546-553.
View at Publisher | View at Google Scholar -
Lagouge M, et al. Resveratrol improves mitochondrial function through SIRT1. Cell. 2006;127:1109-1122.
View at Publisher | View at Google Scholar -
Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144:266-273.
View at Publisher | View at Google Scholar -
Ungvari Z, et al. Resveratrol confers endothelial protection via Nrf2. Am J Physiol Heart Circ Physiol. 2010;299:H18-24.
View at Publisher | View at Google Scholar -
Singh UP, et al. Resveratrol inhibits Th17 immune response. J Immunol. 2007;179:4990-4998.
View at Publisher | View at Google Scholar -
Wang J, et al. Resveratrol regulates Treg/Th17 balance. Clin Immunol. 2016;163:52-60.
View at Publisher | View at Google Scholar -
Lee M, et al. Resveratrol attenuates allergic airway inflammation. Int Immunopharmacol. 2009;9:418-424.
View at Publisher | View at Google Scholar -
Knobloch J, et al. Resveratrol attenuates cigarette smoke-induced inflammation. Thorax. 2011;66:987-993.
View at Publisher | View at Google Scholar -
Calder PC. Nutrition, immunity and public health. Proc Nutr Soc. 2020;79:1-9.
View at Publisher | View at Google Scholar